Commonwealth Equity Services’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Commonwealth Equity Services's BEAM Position: Q2 2026 in Review
Commonwealth Equity Services opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 8,420 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #3788 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in BEAM as recently as Q4 2025.
Commonwealth Equity Services first reported a position in BEAM in Q4 2020 and has held it in 14 quarters since. The position peaked at $939K in Q2 2021. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Commonwealth Equity Services held 8,420 shares of Beam Therapeutics worth $289K as of Q2 2026.
- Beam Therapeutics was a new Commonwealth Equity Services position in Q2 2026.
- Beam Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3788 holding.
- Commonwealth Equity Services first reported a position in Beam Therapeutics in Q4 2020 and has held it in 14 quarters since.
- Commonwealth Equity Services's Beam Therapeutics position peaked at $939K in Q2 2021.
- 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.